Pharma Marketing News Vol. 11, No. 4: 19 April 2012

Welcome to Volume 11, Issue #4 (19 APRIL 2012) of Pharma Marketing News.

Sanofi Launches Diabetapedia: “Google” for Diabetes

Laura Kolodjeski (@lkolodjeski), Community Manager for Sanofi US Diabetes, sent me a Twitter DM announcing the launch of Diabetapedia (di-ah-bee-tah-pee-dee-ah), a new site 'to help meet educational needs of diabetes community.' According to Laura, the goal is to create 'a single, comprehensive place where anyone can find and share definitions of diabetes-related terms and phrases.' The site's tag line is 'Diabetes doesn't define you... so define diabetes.'

Pharma Marketing News Vol. 11, No. 4: 19 April 2012

Welcome to Volume 11, Issue #4 (19 APRIL 2012) of Pharma Marketing News.

Lipitor Holds Key to DTC Ad Spending in 2012

As reported by Nielsen, direct-to-consumer (DTC) advertising spending by the pharmaceutical industry was down by 1% compared to 2010. I did a little exercise to predict that DTC spending in 2012 will see a further 3% decrease compared to 2011 solely due to an expected drop in Lipitor advertising. Here's how I came up with that estimate.

Pharma Marketing News Vol. 11, No. 4: 19 April 2012

Welcome to Volume 11, Issue #4 (19 APRIL 2012) of Pharma Marketing News.

Focus on Drug Safety Communication & TV DTC Advertising

This article reviews two recently published and important guidances from the FDA that concern the dissemination of drug information to consumers.

US Drug Shortage & Supply Chain Crisis

Although many pharmaceutical companies actively use Twitter and other social media tools to push out positive news about their companies and products, very few use these tools for systematic support of patients who depend upon their drugs, which may be short supply.

Do Drug Copay Coupons Drive Up Healthcare Costs?

Coupons for drug co-payments are illegal and drive up long-term health-care costs for all, a consumer group and four trade-union health-insurance plans said in announcing lawsuits against eight pharmaceutical companies. The lawsuits claim that although coupons reduce the consumer's out-of-pocket cost, the health insurer still pays the previously negotiated price to the drug company. With no savings from generics, health plans will need to charge patients more to keep up with rising costs, the lawsuits say.

Pharma Marketing News Vol. 11, No. 3: 19 March 2012

Welcome to Volume 11, Issue #3 (19 MARCH 2012) of Pharma Marketing News.

Pharma Marketing News Vol. 11, No. 2: 22 February 2012

Welcome to Volume 11, Issue #2 (22 FEBRUARY 2012) of Pharma Marketing News.

STAY CONNECTED

30,126FollowersFollow
- Advertisement -